A new Canadian study has reshaped what we know about opioid overdose survival risk. The findings come from ICES and the Centre for Addiction and Mental Health (CAMH) in Toronto. They show that surviving an overdose does not mean the danger has passed. In fact, the months that follow are more deadly than most people realise.
What the Research Found About Non-Fatal Opioid Overdose Outcomes
Researchers tracked 28,488 opioid overdose survivors in Ontario, Canada. All had visited an emergency department between 2017 and 2023 following a non-fatal opioid overdose. Participants ranged in age from 15 to 105 years. The team used linked administrative health data to follow each person for 12 months after discharge.
The results were stark. Within one year, 9 per cent of individuals had died. Another 21 per cent had experienced a repeat overdose. Older studies placed post-overdose mortality at roughly 6 per cent. These new figures are considerably higher.
The risk was sharpest in the first weeks after leaving hospital:
- Within seven days: 0.6% had died and 2% had experienced another overdose
- Within 30 days: 2% had died and 6% had experienced another overdose
People with a history of prior overdoses faced an even greater risk of dying in the year that followed.
Why Opioid Overdose Survival Risk Is Higher Today
The rise in opioid overdose survival risk is not accidental. Lead author Dr Robert Kleinman is a scientist with the Institute for Mental Health Policy Research at CAMH. He pointed directly to the changing drug supply.
“Most older studies were conducted before the introduction of fentanyl into the unregulated drug supply,” Dr Kleinman said. “The current fentanyl supply is highly toxic and associated with a greater risk of overdose or death.”
Fentanyl is a synthetic opioid. It is far more potent than heroin or most prescription opioids. Its spread through the unregulated supply has made opioid use dramatically more unpredictable and lethal. This is true even for those who have used drugs for years.
The Critical Window After a Non-Fatal Opioid Overdose
Non-fatal opioid overdose outcomes do not stabilise once someone leaves hospital. The first seven to thirty days after discharge carry the highest risk. This is a period of acute vulnerability that the health system too often overlooks.
Many individuals are stabilised in emergency and then discharged. They leave without sufficient support or follow-up. Without structured intervention during this window, the risk of death or repeat overdose stays dangerously high.
Dr Paul Kurdyak is a senior scientist with ICES and CAMH. He was direct: “The elevated mortality risk observed in this study is highly concerning. Evidence-based care pathways for individuals who show up to an emergency department with an overdose may help reduce the high mortality rate and help people access treatment.”
What Needs to Change
Understanding opioid overdose survival risk is only useful if it drives change. The research points to a clear need for structured, evidence-based pathways at the point of emergency care. Individuals should leave hospital with proper referrals and follow-up appointments in place. Access to treatment for opioid use disorder must be part of that process.
Opioid agonist treatments such as methadone or buprenorphine have strong evidence behind them. They reduce opioid-related deaths and improve long-term outcomes. Connecting people to these treatments after an overdose could save many lives.
The Bigger Picture
The researchers acknowledged one limitation. Overdoses that did not result in an emergency department visit were not captured. This means the true rate of repeat overdose in the community is likely even higher. The 21 per cent figure may already be an underestimate.
Opioid-related deaths are not inevitable. They are preventable. When someone survives an overdose, it is both a crisis and a moment for real intervention. The weeks that follow matter more than most people know. The health system’s response during that time can determine whether someone lives or dies.
(Source: WRD News)